With a strong scientific-phase pipeline, Agenus harnesses a combination of proprietary antibody platforms, which include Retrocyte Show™ and SECANT®, and ground breaking cell therapy methods, positioning by itself for a key contributor from the biotechnology and immunotherapy arena. The